Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply to S. Zeng et al

Christian Pfister1, Valentin Harter1, Yves Allory1

  • 1Christian Pfister, MD, PhD, Department of Urology, Charles Nicolle University Hospital, Rouen, France, Clinical Investigation Center, Onco-Urology, Inserm 1404, Rouen, France; Valentin Harter, MSc, North-West Canceropole Data Center, Baclesse Cancer Center, Caen, France; Yves Allory, MD, PhD, Department of Pathology, Curie Institute, Saint-Cloud, France; and Stéphane Culine, MD, PhD, Department of Medical Oncology, Saint-Louis Hospital, AP-HP, Faculté de Paris, Paris, France.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|June 15, 2022
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer.

Nature communications·2024
Same author

The genomic and transcriptomic landscape of metastastic urothelial cancer.

Nature communications·2024
Same author

Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors.

The Journal of pathology·2024
Same author

Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.

NPJ precision oncology·2024
Same author

Perioperative chemotherapy in bladder cancer: the more cisplatin, the best survival?

World journal of urology·2024